Literature DB >> 17683920

Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent.

Taizo Hasegawa1, Keiji Hirota, Keishiro Tomoda, Fuminori Ito, Hiroyuki Inagawa, Chie Kochi, Gen-Ichiro Soma, Kimiko Makino, Hiroshi Terada.   

Abstract

Phagocytosis of alveolar macrophages (Mphis) toward poly(lactic-co-glycolic acid) (PLGA) microspheres (MS) loaded with the anti-tuberculosis agent rifampicin (RFP-PLGA MS) has been shown to be effective for the treatment of tuberculosis. The phagocytosis should be evaluated in terms of that toward reference MS. We chose polystyrene latex (PSL) MS as a reference. In this study, phagocytic activity of cell line NR8383, derived from rat alveolar Mphi, toward PSL MS with various diameters was examined by incubating the cells for 4h at 37 degrees C with various numbers of PSL MS per Mphi cell (MS/Mphi=0.1-10). The results were then compared with those of the phagocytosis toward RFP-PLGA MS. We determined the phagocytic activity by counting the population of Mphi cells that had phagocytosed MS (N) and the number of particles phagocytosed (n) in microscopic fields. Both N and n for PSL and RFP-PLGA MS increased in general with an increase in MS/Mphi, but both of these values for PSL MS were smaller than those for RFP-PLGA MS. Phagocytosis of the particles were dependent on the particle size; i.e., of the PSL MS the 6-mum ones were taken up by Mphi the most, and the RFP-PLGA MS 3 microm in diameter seemed to be phagocytosed the most efficiently, although we were not able to determine exactly the phagocytosis of 6- and 10-microm RFP-PLGA MS. From the changes in N and n values with MS/Mphi, the phagocytosis of RFP-PLGA MS was likely to enhance the phagocytic activity of Mphi cells, but this effect did not seem to be significant for PSL MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17683920     DOI: 10.1016/j.colsurfb.2007.06.017

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  6 in total

Review 1.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

2.  Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration.

Authors:  Ryan Gene Soderquist; Evan M Sloane; Lisa C Loram; Jacqueline A Harrison; Ellen C Dengler; Scott M Johnson; Luke D Amer; Courtney S Young; Makenzie T Lewis; Stephen Poole; Matthew G Frank; Linda R Watkins; Erin D Milligan; Melissa J Mahoney
Journal:  Pharm Res       Date:  2010-03-12       Impact factor: 4.200

3.  Stimulation of phagocytic activity of alveolar macrophages toward artificial microspheres by infection with mycobacteria.

Authors:  Keiji Hirota; Keishiro Tomoda; Hiroyuki Inagawa; Chie Kohchi; Gen-Ichiro Soma; Kimiko Makino; Hiroshi Terada
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

Review 4.  Micro- and nanoplastics - current state of knowledge with the focus on oral uptake and toxicity.

Authors:  Maxi B Paul; Valerie Stock; Julia Cara-Carmona; Elisa Lisicki; Sofiya Shopova; Valérie Fessard; Albert Braeuning; Holger Sieg; Linda Böhmert
Journal:  Nanoscale Adv       Date:  2020-09-02

Review 5.  Synthetic Nanoparticles for Vaccines and Immunotherapy.

Authors:  Darrell J Irvine; Melissa C Hanson; Kavya Rakhra; Talar Tokatlian
Journal:  Chem Rev       Date:  2015-07-08       Impact factor: 60.622

6.  Systems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of Tuberculosis.

Authors:  N A Cilfone; E Pienaar; G M Thurber; D E Kirschner; J J Linderman
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.